Logan Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-17,546
Closed -$4.04M 287
2016
Q3
$4.04M Sell
17,546
-183
-1% -$44.7K 0.33% 81
2016
Q2
$4.1M Buy
17,729
+979
+6% +$226K 0.35% 75
2016
Q1
$4.49M Buy
16,750
+206
+1% +$59K 0.36% 74
2015
Q4
$5.17M Buy
16,544
+168
+1% +$50K 0.41% 65
2015
Q3
$4.45M Buy
16,376
+97
+0.6% +$29.8K 0.37% 73
2015
Q2
$4.94M Sell
16,279
-572
-3% -$171K 0.36% 73
2015
Q1
$5.01M Sell
16,851
-96
-0.6% -$27.4K 0.35% 76
2014
Q4
$4.36M Sell
16,947
-3,213
-16% -$803K 0.32% 81
2014
Q3
$4.86M Buy
20,160
+586
+3% +$131K 0.35% 75
2014
Q2
$4.37M Sell
19,574
-156
-0.8% -$32.3K 0.31% 81
2014
Q1
$4.06M Buy
19,730
+1,417
+8% +$281K 0.29% 85
2013
Q4
$3.08M Buy
+18,313
New +$2.86M 0.22% 94

Other funds holding AGN

Logan Capital Management's AGN Position: Q4 2016 in Review

Logan Capital Management sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 17,546 shares — an estimated $4.04M sold.

Logan Capital Management first reported a position in AGN in Q4 2013 and held it in 12 quarters. The position peaked at $5.17M in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Logan Capital Management reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Logan Capital Management sold 17,546 Allergan plc shares in Q4 2016, an estimated $4.04M.
  • Logan Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 12 quarters.
  • Logan Capital Management's Allergan plc position peaked at $5.17M in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Logan Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.